Vaccination represents a mainstay in preventing infection but, in patients with multiple sclerosis (MS), this therapeutic approach can carry the risk of triggering a relapse. Hartung and colleagues review the safety of vaccines against various infections in patients with MS, and discuss the issue of vaccine efficacy in the context of disease-modifying MS drugs.
- Micha Loebermann
- Alexander Winkelmann
- Uwe K. Zettl